Recover complete and accurate genetic, epigenetic and fragmentomic information from the same limited sample, to build a more complete view of the biology and achieve ultra-low limits of detection (LoD) in your liquid biopsy research.
Each cfDNA molecule contains several layers of information. Studied together, these layers can provide complementary biomarkers of biological state, disease-associated processes and the origins of cfDNA.
Identify sequence variation associated with disease, clonal populations or inherited biology, including low-frequency variants.
Measure DNA modifications that reflect regulatory state, cellular identity and biological activity beyond the underlying sequence.
Preserve native fragment characteristics and investigate structural patterns that may provide an additional source of biological signal.
cfDNA is precious, fragmented and often available at low input. Current approaches can force researchers to compromise by:
The duet mosaic portfolio is designed to get more from limited cfDNA, bringing high accuracy and complete genetic, epigenetic and fragmentomic information together in a single workflow to achieve ultra-low LoD.
Make more of precious cfDNA without splitting limited material across separate assays.
Single-stranded ligation improves recovery of short, damaged and single-stranded fragments that are otherwise lost.
Read genetics, epigenetics and fragmentomics together from the same DNA molecule, rather than prioritizing one signal at the expense of another.
Bring complementary molecular information together without having to reconcile outputs from separate workflows.
High accuracy, more complete molecular information and improved fragment recovery combine to support ultra-low limits of detection, helping reveal rare disease-derived cfDNA that might otherwise be missed.
Identify and evaluate combinations of genetic, epigenetic and fragmentomic features associated with a biological state or disease process.
Investigate sequence variation, regulatory state and fragment patterns as distinct but complementary dimensions of disease biology.
Build and test research classifiers using features from multiple molecular layers rather than relying on one signal alone.
Explore epigenetic and fragmentomic features to understand the biological origins of cfDNA.
Study how molecular signals change across serial samples in translational and disease-monitoring research.
Detect rare ctDNA at ultra-low LoDs by combining genetic, epigenetic and fragmentomic signals, supporting research in early cancer detection, MCED, MRD and longitudinal disease monitoring.
Identify novel biomarkers from plasma or cerebrospinal fluid cfDNA to better detect and understand neurological disease.
See how 6-base sequencing profiles cerebrospinal fluid cfDNA in neurological liquid biopsy research.
Explore research and on-demand sessions spanning native cfDNA feature preservation, neurological liquid biopsy, treatment resistance and early-stage cancer biomarker discovery.
All resourcesLearn why preserving native cfDNA features matters for achieving ultra-low LoD and fragment-level liquid biopsy analysis.
Watch the webinar →Explore neurological liquid biopsy research using cfDNA released from neural cells into cerebrospinal fluid.
Read the research →See how serial plasma cfDNA and 6-base sequencing were used to investigate tumour phenotypes and resistance patterns over time.
Watch the webinar →Explore evidence for 5mC and 5hmC as synergistic cfDNA biomarkers for early-stage colorectal cancer detection.
Read the publication summary →Choose the level of epigenetic resolution that best fits your biological question.
duet +modC mosaic Generate genetic, modified cytosine and native fragmentomic information from limited cfDNA through one streamlined workflow. | duet 6-base mosaic Resolve genetics, 5mC, 5hmC and fragmentomics independently from the same limited cfDNA sample. | |
|---|---|---|
| High-confidence genetic information | ✓ | ✓ |
| Cytosine modification readout | Modified cytosine measurement | Independent 5mC and 5hmC resolution |
| Native fragment characteristics | ✓ | ✓ |
| Designed for low-input cfDNA | ✓ | ✓ |
| A strong fit when … | …integrated genetics, modC and fragmentomics answer the study question. | …biologically distinct 5mC and 5hmC signals are important to the research question. |
| Explore duet +modC mosaic | Explore duet 6-base mosaic |
Generate genetic, modified cytosine and native fragmentomic information from limited cfDNA through one streamlined workflow.
A strong fit when … integrated genetics, modC and fragmentomics answer the study question.
Explore duet +modC mosaicResolve genetics, 5mC, 5hmC and fragmentomics independently from the same limited cfDNA sample.
A strong fit when … biologically distinct 5mC and 5hmC signals are important to the research question.
Explore duet 6-base mosaicTalk with a biomodal scientist about your sample type, input, biological question and the level of multiomic resolution your study requires.
Talk to a scientist